Patent AnalyticsExaminers
Menu

Application

18825304 · COMBINATION THERAPY WITH A CEA X CD28 BISPECIFIC ANTIBODY AND BLOCKING ANTI-PD-1 ANTIBODIES FOR ENHANCED IN VIVO ANTI-TUMOR ACTIVITY

Filed 2024-09-05 · Pending The official file ↗ · Art unit OPAP · Examiner Docket Central Easy · CPC C07K 16/2818 · Novimmune SA · FENWICK & WEST LLP

Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in